Navigation Links
Juvéderm Voluma Declared Effective by the FDA

Los Angeles, CA (PRWEB) May 16, 2013

According to an April 30, 2013 CNBC article, titled “FDA Staff Says Allergan's New Dermal Filler Effective” (Go to, the US Food and Drug Administration (FDA) recently declared that Juvéderm Voluma XC, a dermal filler product manufactured by Allergan Inc., is effective in correcting volume deficits in the middle of the face. The FDA reported that after six months of Juvéderm Voluma XC treatments, there is a significant improvement in the appearance of facial wrinkles and folds in the center of the face.

“I look forward to being able to offer Juvéderm Voluma XC to my patient,” says Dr. Simon Ourian, Medical Director of Epione Beverly Hills. “Everything I’ve heard and read until now indicates that it works well to restore lost facial volume.”

The article noted that the FDA reviewers who conducted the preliminary review of Juvéderm Voluma XC indicated that if the FDA advisory panel approved the dermal filler, Allergan should be compelled to perform further safety tests. Before the approval was announced, some analysts had predicted that based on Allergan Inc.’s track record and the quality of the other products manufactured by the company, there was a high likelihood of the FDA clearing Juvéderm Voluma XC.

Although two of the FDA reviewers initially dissented from the opinion, on May 2, 2013 the independent advisory panel of the Federal Drug Administration voted on the safety, effectiveness and risk benefit profile of this dermal filler, and unanimously declared that is an effective injectable that has the ability to correct age related problems such as folds and wrinkles in the mid-face.

“It is important to note that prior to the FDA's declaration that Juvéderm Voluma XC is effective, it had previously approved an earlier version of Juvéderm in 2006,” says Dr. Ourian, “and I’ve been using it in my practice since that time. I found it to be an effective product and I expect Juvéderm Voluma to be a benefit to my patients too.”

Dr. Ourian has been a pioneer in laser technology and non-invasive aesthetic procedures including Restylane, Juvéderm, Radiesse and Sculptra. These treatments are used for the correction or reversal of a variety of conditions such as acne, acne scars, skin discoloration, wrinkles, stretch marks, varicose veins, cellulite, and others. More information about the pending approval of Juvéderm Voluma XC can be found on Epione’s website.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Days for Girls International Declared a Nike Girl Effect Champion
2. Pelvic organ prolapse surgery less effective than expected
3. Procedure for Incontinence in Women May Lose Effectiveness With Time
4. New Global Study Pinpoints Main Causes of Childhood Diarrheal Diseases, Suggests Effective Solutions
5. Weight Loss Solutions
6. How “Customized Fat Loss” Helps People Lose Fat Effectively – V kool
7. Dermatologists in San Diego Say Botox is a Safe & Effective Treatment for Migraine & Tension Headache Relief
8. Silk and cellulose biologically effective for use in stem cell cartilage repair
9. Exercise proves to be ineffective against care home depression
10. Weight loss surgery safe and effective for an expanded group of patients
11. Mariner Biomedical Announces Results From an Independent Laboratory Confirming Deter Insect Repellent™ Effectively Repels Mosquitoes for 6 Hours
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
Breaking Medicine Technology: